PhotoDynamic Inc. product goes for research trial in Boston
Martin Greenwood (BSc’00, MBA’04) is CEO of Halifax-based PhotoDynamic Inc., which is set to test its oral plaque-fighting system at a prestigious research facility in Boston.
—
Halifax-based PhotoDynamic Inc. will put its plaque-killing oral health product through clinical trials in the next month, the outcome of which will shape its strategy for the next few years.
The company will test its product with 20 patients at the Forsyth Institute in Boston, one of the world’s most prestigious research facilities in the field of oral health. If it gets good results from these tests, the company plans to work closely with a Fortune 100 consumer products company to bring the product to market.
That product — called PD Foam and Tray — is a system that kills plaque buildup on teeth through a combination of light and an extract from a plant that grows wild in Nova Scotia. Because the plant is known to be safe for human consumption, the product has a relatively simple regulatory path. Its initial target market is the one-fifth of the population who suffer from excessive plaque buildup on their teeth regardless of how much they brush.
“We’ll start in a few weeks and have the results by January,” said CEO Martin Greenwood in an interview. “If the results are good, it will be easy to raise our next round (of financing) and then we’ll be moving on to a larger trial.”
Read the full story in “ENTREVESTOR: Halifax startup testing oral plaque-killing product” on thechronicleherald.ca.